This announcement is a separate document:
北京市中银（上海）律师事务所关于重庆智翔金泰生物制药股份有限公司首次公开发行股票并在科创板上市之参与战略配售的投资者核查的法律意见书
Legal opinion of the Beijing Bank of China (Shanghai) Law Firm on the inspection of investors participating in the strategic placement of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd.\'s initial public offering and listing on the Science and Techno
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.